Year |
Citation |
Score |
2023 |
Schumacher TJ, Sah N, Palle K, Rumbley J, Mereddy VR. Synthesis and biological evaluation of benzofuran piperazine derivatives as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 93: 129425. PMID 37557926 DOI: 10.1016/j.bmcl.2023.129425 |
0.821 |
|
2021 |
Nelson GL, Ronayne CT, Solano LN, Jonnalagadda SK, Jonnalagadda S, Schumacher TJ, Gardner ZS, Palle H, Mani C, Rumbley J, Mereddy VR. Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 128411. PMID 34626786 DOI: 10.1016/j.bmcl.2021.128411 |
0.816 |
|
2021 |
Ronayne CT, Jonnalagadda SK, Jonnalagadda S, Nelson GL, Solano LN, Palle H, Mani C, Rumbley J, Holy J, Mereddy VR. Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53. Biochemical and Biophysical Research Communications. 562: 127-132. PMID 34051576 DOI: 10.1016/j.bbrc.2021.05.062 |
0.813 |
|
2021 |
Gardner ZS, Schumacher TJ, Ronayne CT, Kumapti GP, Williams MJ, Yoshimura A, Palle H, Mani C, Rumbley J, Mereddy VR. Synthesis and biological evaluation of novel 2-alkoxycarbonylallylester phosphonium derivatives as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 128136. PMID 34044122 DOI: 10.1016/j.bmcl.2021.128136 |
0.84 |
|
2020 |
Solano LN, Nelson GL, Ronayne CT, Jonnalagadda S, Jonnalagadda SK, Kottke K, Chitren R, Johnson JL, Pandey MK, Jonnalagadda SC, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents. Scientific Reports. 10: 17969. PMID 33087745 DOI: 10.1038/s41598-020-74572-1 |
0.815 |
|
2020 |
Jonnalagadda SK, Wielenberg K, Ronayne CT, Jonnalagadda S, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents. Bioorganic & Medicinal Chemistry Letters. 30: 127259. PMID 32527557 DOI: 10.1016/J.Bmcl.2020.127259 |
0.81 |
|
2020 |
Sadeghzadeh M, Wenzel B, Gündel D, Deuther-Conrad W, Toussaint M, Moldovan RP, Fischer S, Ludwig FA, Teodoro R, Jonnalagadda S, Jonnalagadda SK, Schüürmann G, Mereddy VR, Drewes LR, Brust P. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging. Molecules (Basel, Switzerland). 25. PMID 32423056 DOI: 10.3390/Molecules25102309 |
0.777 |
|
2019 |
Nelson GL, Ronayne CT, Solano LN, Jonnalagadda SK, Jonnalagadda S, Rumbley J, Holy J, Rose-Hellekant T, Drewes LR, Mereddy VR. Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment. Scientific Reports. 9: 18266. PMID 31797891 DOI: 10.1038/S41598-019-54709-7 |
0.818 |
|
2019 |
Khammanivong A, Saha J, Spartz AK, Sorenson BS, Bush AG, Korpela DM, Gopalakrishnan R, Jonnalagadda S, Mereddy VR, O'Brien TD, Drewes LR, Dickerson EB. A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumor growth of feline oral squamous cell carcinoma. Veterinary and Comparative Oncology. PMID 31661586 DOI: 10.1111/Vco.12551 |
0.804 |
|
2019 |
Jonnalagadda S, Jonnalagadda SK, Ronayne CT, Nelson GL, Solano LN, Rumbley J, Holy J, Mereddy VR, Drewes LR. Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors. Oncotarget. 10: 2355-2368. PMID 31040927 DOI: 10.18632/Oncotarget.26760 |
0.822 |
|
2019 |
Sadeghzadeh M, Moldovan RP, Fischer S, Wenzel B, Ludwig FA, Teodoro R, Deuther-Conrad W, Jonnalagadda S, Jonnalagadda SK, Gudelis E, Šačkus A, Higuchi K, Ganapathy V, Mereddy VR, Drewes LR, et al. Development and radiosynthesis of the first F-labeled inhibitor of monocarboxylate transporters (MCTs). Journal of Labelled Compounds & Radiopharmaceuticals. PMID 31017677 DOI: 10.1002/Jlcr.3739 |
0.773 |
|
2019 |
Cong A, Lima Pimenta RM, Mereddy V, Holy JM, Heikal AA. Metabolic-Response Assessment of Murine Breast Cancer Cells in 2D and 3D Cultures using Two-Photon Fluorescence Lifetime Imaging Microscopy of Intrinsic Nad(P)H Biophysical Journal. 116: 421a. DOI: 10.1016/J.Bpj.2018.11.2268 |
0.404 |
|
2018 |
Cong A, Pimenta RML, Lee HB, Mereddy V, Holy J, Heikal AA. Two-photon fluorescence lifetime imaging of intrinsic NADH in three-dimensional tumor models. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 30343512 DOI: 10.1002/cyto.a.23632 |
0.296 |
|
2017 |
Ronayne CT, Solano LN, Nelson GL, Lueth EA, Hubbard SL, Schumacher TJ, Gardner ZS, Jonnalagadda SK, Gurrapu S, Holy J, Mereddy VR. Synthesis and biological evaluation of 2-alkoxycarbonylallyl esters as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. PMID 28129978 DOI: 10.1016/J.Bmcl.2017.01.037 |
0.826 |
|
2016 |
Alam MA, Arora K, Gurrapu S, Jonnalagadda SK, Nelson GL, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents. Tetrahedron. 72: 3795-3801. PMID 27642196 DOI: 10.1016/J.Tet.2016.03.038 |
0.82 |
|
2016 |
Gurrapu S, Jonnalagadda SK, Alam MA, Ronayne CT, Nelson GL, Solano LN, Lueth EA, Drewes LR, Mereddy VR. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. PMID 27241692 DOI: 10.1016/J.Bmcl.2016.05.054 |
0.805 |
|
2016 |
Alam MA, Arora K, Gurrapu S, Jonnalagadda SK, Nelson GL, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents Tetrahedron. DOI: 10.1016/j.tet.2016.03.038 |
0.82 |
|
2015 |
Solano LN, Nelson GL, Ronayne CT, Lueth EA, Foxley MA, Jonnalagadda SK, Gurrapu S, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 25: 5777-80. PMID 26561365 DOI: 10.1016/J.Bmcl.2015.10.061 |
0.814 |
|
2015 |
Gurrapu S, Jonnalagadda SK, Alam MA, Nelson GL, Sneve MG, Drewes LR, Mereddy VR. Monocarboxylate transporter 1 inhibitors as potential anticancer agents. Acs Medicinal Chemistry Letters. 6: 558-61. PMID 26005533 DOI: 10.1021/Acsmedchemlett.5B00049 |
0.832 |
|
2013 |
Tekkam S, Alam MA, Just MJ, Berry SM, Johnson JL, Jonnalagadda SC, Mereddy VR. Stereoselective synthesis of pyroglutamate natural product analogs from α- aminoacids and their anti-cancer evaluation. Anti-Cancer Agents in Medicinal Chemistry. 13: 1514-30. PMID 23848201 DOI: 10.2174/18715206113139990097 |
0.814 |
|
2013 |
Sravan Kumar J, Alam MA, Gurrapu S, Nelson G, Williams M, Corsello MA, Johnson JL, Jonnalagadda SC, Mereddy VR. Synthesis and biological evaluation of novel benzoxaboroles as potential antimicrobial and anticancer agents Journal of Heterocyclic Chemistry. 50: 814-820. DOI: 10.1002/Jhet.1777 |
0.801 |
|
2013 |
Tekkam S, Johnson JL, Jonnalagadda SC, Mereddy VR. Concise synthesis of α-methylene-β-hydroxy-γ-carboxy- γ-lactams Journal of Heterocyclic Chemistry. 50: 955-958. DOI: 10.1002/Jhet.1578 |
0.819 |
|
2013 |
Tekkam S, Johnson JL, Jonnalagadda SC, Mereddy VR. An efficient synthesis of [2.2.1] heterobicyclic pyroglutamates Journal of Heterocyclic Chemistry. 50: 969-972. DOI: 10.1002/Jhet.1097 |
0.842 |
|
2013 |
Kumar JS, Alam MA, Gurrapu S, Nelson G, Williams M, Corsello MA, Johnson JL, Jonnalagadda SC, Mereddy VR. ChemInform Abstract: Synthesis and Biological Evaluation of Novel Benzoxaboroles as Potential Antimicrobial and Anticancer Agents. Cheminform. 44: no-no. DOI: 10.1002/CHIN.201351210 |
0.82 |
|
2013 |
Tekkam S, Johnson JL, Jonnalagadda SC, Mereddy VR. ChemInform Abstract: An Efficient Synthesis of [2.2.1]Heterobicyclic Pyroglutamates. Cheminform. 44: no-no. DOI: 10.1002/CHIN.201351144 |
0.308 |
|
2012 |
Just MJ, Tekkam S, Alam MA, Jonnalagadda SC, Johnson JL, Mereddy VR. Corrigendum to “Stereoselective synthesis of functionalized pyroglutamates” [Tetrahedron Lett. 52 (2011) 5349–5351] Tetrahedron Letters. 53: 363. DOI: 10.1016/J.Tetlet.2011.11.064 |
0.771 |
|
2012 |
Jonnalagadda SC, Corsello MA, Hetzell BR, Mereddy VR. ChemInform Abstract: Synthetic Applications of Suzuki-Miyaura Cross-Coupling Reaction Cheminform. 43: no-no. DOI: 10.1002/chin.201210247 |
0.757 |
|
2012 |
Just MJ, Tekkam S, Alam MA, Jonnalagadda SC, Johnson JL, Mereddy VR. ChemInform Abstract: Stereoselective Synthesis of Functionalized Pyroglutamates. Cheminform. 43: no-no. DOI: 10.1002/CHIN.201205215 |
0.336 |
|
2011 |
Tekkam S, Alam MA, Jonnalagadda SC, Mereddy VR. Novel methodologies for the synthesis of functionalized pyroglutamates. Chemical Communications (Cambridge, England). 47: 3219-21. PMID 21318205 DOI: 10.1039/C0Cc05609J |
0.797 |
|
2011 |
Just MJ, Tekkam S, Alam MA, Jonnalagadda SC, Johnson JL, Mereddy VR. Stereoselective synthesis of functionalized pyroglutamates Tetrahedron Letters. 52: 5349-5351. DOI: 10.1016/J.Tetlet.2011.08.029 |
0.823 |
|
2010 |
Kumar JS, Bashian CM, Corsello MA, Jonnalagadda SC, Mereddy VR. Development of Practical Methodologies for the Synthesis of Functionalized Benzoboroxoles. Tetrahedron Letters. 51: 4482-4485. PMID 20824154 DOI: 10.1016/J.Tetlet.2010.06.077 |
0.794 |
|
2010 |
Kumar JS, Jonnalagadda SC, Mereddy VR. An Efficient Boric Acid Mediated Preparation of α-Hydroxyamides. Tetrahedron Letters. 51: 779-782. PMID 20161580 DOI: 10.1016/J.Tetlet.2009.12.008 |
0.792 |
|
2010 |
Jonnalagadda SC, Verga SR, Patel PD, Reddy AV, Srinivas T, Scott PM, Mereddy VR. Novel methodologies for the synthesis of functionalized lipophilic carboranes Applied Organometallic Chemistry. 24: 294-300. DOI: 10.1002/Aoc.1598 |
0.799 |
|
2009 |
Jonnalagadda SC, Cruz JS, Connell RJ, Scott PM, Mereddy VR. Synthesis of α-carboranyl-α-acyloxy-amides as potential BNCT agents. Tetrahedron Letters. 50: 4314-4317. PMID 20160970 DOI: 10.1016/J.Tetlet.2009.05.026 |
0.816 |
|
Low-probability matches (unlikely to be authored by this person) |
2024 |
Schumacher TJ, Gardner ZS, McParlan MP, Omy T, Palle K, Rumbley J, Mereddy VR. Synthesis and Biological Evaluation of Telmisartan Alkylamine Derivatives as Potential Anticancer Agents. Anticancer Research. 44: 911-919. PMID 38423633 DOI: 10.21873/anticanres.16885 |
0.12 |
|
Hide low-probability matches. |